BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: Leonard Braden Michael
Security: Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share
Symbol: ADVM
Shares outstanding: 20,819,333 shares
Disclosed Ownership: 2,373,404 shares
Ownership: 11%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 15:25:11 UTC
Date of event: 31 Dec 2024
Next filing: 06 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	11%	2,268,604	0	2,268,604	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Leonard Braden Michael	11%	2,373,404	104,800	2,268,604	Braden M Leonard	Leonard Braden Michael